期刊文献+

1%吡美莫司乳膏治疗疥疮结节的疗效观察

Clinical Observation of 1% Pimecrolimus Cream in the Treament of Scabies Nodule
下载PDF
导出
摘要 目的观察1%吡美莫司乳膏治疗疥疮结节的临床疗效及安全性。方法 82例确诊的具有典型疥疮结节的患者,随机分为治疗组和对照组各41例,先予10%克罗米通乳膏正规治疗疥疮,并分别较早地使用1%吡美莫司乳膏和0.05%卤米松乳膏,外涂外阴部疥疮结节,均2次/d4周后观察疗效。结果治疗4周后,治疗组有效率为68.3%,对照组为75.6%,两组有效率差异无统计学意义(P>0.05),治疗组不良反应较少。结论 1%吡美莫司乳膏治疗疥疮结节安全、有效,在知情同意下可临床应用。 Objective To investigate the clinical efficacy and safety of 1% pimecrolimus cream for the treatment of sca-bies nodule. Methods Eighty-two patients with scabies nodules were randomly divided into test group(41 cases) and control group(41 cases) and regularly treated with 10% crotamiton first. The test group were treated with 1% pimecrolimus cream for 4 weeks in the early time, while the control group were treated with 0.05% halometasone cream. Results Four weeks after the treatment, the effective rate in the test group was 68.3%, and 75.6% respectively in the control group. There was no significant difference(P 〉0.05) between the test and control groups. Almost no adverse effects were occurred in the test group during the pe-riods of treatment. Conclusion 1% pimecrolimus cream may be a safe and effective treatment for the pa-tients with scabies nodule, but to informed consent.
作者 龚士伟
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第5期539-540,共2页 The Chinese Journal of Dermatovenereology
关键词 疥疮 结节 吡美莫司乳膏 Scabies, nvdule Pimecrolimus cream
  • 相关文献

参考文献3

二级参考文献25

  • 1杨军.卤米松乳膏治疗疥疮结节35例[J].中国皮肤性病学杂志,2004,18(11). 被引量:4
  • 2Werfel T. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy[J].J Dtsch Dermatol Ges, 2009,7:739-742.
  • 3Schneeweiss S, Doherty M, Zhu S,et al. Topical treatments with pimecrolimus, tacrolimus and medium-to high-potency corticos- teroids, and risk of lymphoma[J].Dermatology, 2009,219:7-2 l.
  • 4Huhsch T, Kapp A, Spergel J. irnmunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis [J]. Dermatology, 2005, 211 : 174-187.
  • 5Gupta AK, Chow M.Pimecrolimus: a review[J]. J Eur Acad Dermatol Venereol, 2003, 17:493-503.
  • 6Iraji F, Asilian A, Siadat AH, et al.Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double- blind, placebo-controlled clinical trial[J].J Drugs Dermatol, 2010,9: 684-686.
  • 7Kose O, Arca E, Kurumlu Z, et al.Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo [J].J Dermatolog Treat, 2010, 21:133-139.
  • 8Esfandiarpour I, Ekhlasi A, Farajzadeh S, et al.The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial[J]. J Dermatolog Treat, 2009, 20:14-18.
  • 9Cicek D, Kandi B, Bakar S, et al. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study[J]. J Dermatolog Treat, 2009,20:344-349.
  • 10Ozden MG, Tekin NS, Ilter N, et al.Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study [J].Am J Clin Dermatol, 2010,11:51-54.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部